Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fractional exhaled nitric oxide (FeNO): the future of asthma care?

Journal article

Wang K. et al, (2023), The British journal of general practice : the journal of the Royal College of General Practitioners, 73, 565 - 568

Which biologic? New findings from a real‐world study

Journal article

Lavoie G. and Pavord ID., (2023), Respirology

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.

Journal article

Hughes R. et al, (2023), The journal of allergy and clinical immunology. In practice, 11, 2803 - 2811

Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.

Journal article

Maspero JF. et al, (2023), Respiratory medicine, 218

European Respiratory Society Short Guidelines for the use of as-needed ICS/formoterol in mild Asthma.

Journal article

Papi A. et al, (2023), The European respiratory journal

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight

Journal article

Howell I. et al, (2023), Journal of Experimental Medicine, 220

Gold 2023: Highlights for primary care.

Journal article

Agustí A. et al, (2023), NPJ primary care respiratory medicine, 33

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight.

Journal article

Howell I. et al, (2023), The Journal of experimental medicine, 220

Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control.

Journal article

Zeng X. et al, (2023), The Journal of allergy and clinical immunology

Clinically accessible biomarkers to assess the modifiable risk of asthma/wheezing attacks in toddlers

Journal article

Couillard S. et al, (2023), Journal of Allergy and Clinical Immunology: In Practice, 11, 1984 - 1985

Air pollution and COPD: GOLD 2023 committee report.

Journal article

Sin DD. et al, (2023), The European respiratory journal, 61

Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthma.

Journal article

Sher LD. et al, (2023), The Journal of asthma : official journal of the Association for the Care of Asthma, 1 - 8

The Lancet COPD Commission: broader questions remain

Journal article

Petousi N. et al, (2023), The Lancet, 401, 1569 - 1570

Load More